"First Time in History Of Cancer"; 18 Cancer Patients completely cured after an experimental treatment

"First Time in History Of Cancer"; 18 Cancer Patients completely cured after an experimental treatment

It can be said that an experimental treatment for rectal cancer ended up being a miracle or blessing as this small group of patients' cancer simply disappeared after their treatment. According to New York Times, 18 patients participated in a very small clinical trial, and they all saw their tumours disappear after taking a drug called Dostarlimab for about six months.

A drug called dostarlimab consists of chemical molecules produced in a lab that act as substitute antibodies in the body. The same drug was given to all 18 rectal cancer patients, as a result of which, cancer was completely obliterated - undetectable by physical examination, endoscopy, or positron emission tomography or PET scans.

This is "the first time this has happened in the history of cancer," according to Dr. Luis A. Diaz J. of Memorial Sloan Kettering Cancer Center in New York.

It's too early to determine if all of the patients will remain in remission or if the treatment will work for other types of rectal cancer, but the results are "reason for considerable optimism," according to one expert. The results of the small trial, which took place at the MSK Cancer Center in New York City, were published in the New England Journal of Medicine on Sunday (June 5).

The discoveries have caused a stir in the medical community. Dr. Alan P. Venook, a colon cancer specialist at the University of California, told the news source that complete remission in every single patient is "unheard-of." He lauded the study as a first of its kind in the globe. He went on to say that it was especially impressive because not all of the patients experienced significant side effects from the trial medicine.

According to the media outlet, cancer researchers who reviewed the drug said it is promising, but a larger-scale trial is needed to determine whether it will be effective for more patients and whether the cancer may be in remission for good.

What's Your Reaction?